Contraindications and monitoring
We wanted to resolve the lack of consensus with our work. Analyzing de-identified patient data collected from December 2017 through December 2024 across 12 databases managed by the Observational Health Data Sciences and Informatics (OHDSI) network-an international and interdisciplinary collaborative of researchers and observational health databases the researchers followed the health outcomes of adults with type 2 diabetes who had been prescribed semaglutide (227,971), dulaglutide (68,588), exenatide (5,460), empagliflozin (252,356), sitagliptin (100,083) or glipizide (213,515) for the first time
Duration varies depending on individual progress, maintenance ability, and long-term weight stability after treatment
The trend: Consumers who take weight loss drugs are eating less and consuming healthier foods when theyre on the medication
Whether you aim for overall skin lightening or targeting specific areas, this information will help guide the dosage and duration recommendations